STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
93
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $2.2M priced
What the filings say about VREX
Insiders, 180 days
-$2.6M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$2.6M
2 notices
Varex Imaging insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Varex Imaging Corp insiders sold a net $2.6M of stock across 21 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Mar 20, 2026.
The trade is 53.0% of the 15,329 shares held after it.
1 other insider sold within 30 days.
93 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Kunkel Jay K. sold about $150.1K of VREX on Sep 14, 2026; 1 other insider sold within 30 days and 93 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Aug 12, 2024.
+31.5% median (+31.5% mean) 90-day return after 2 previous buys.
The trade is 92.9% of the 139,972 shares held after it.
1 other insider sold within 30 days.
93 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Maheshwari Shubham sold about $2.4M of VREX on Sep 11, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days and 93 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
VREX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Kunkel Jay K.
Filed 2026-09-14
$150.1K
Maheshwari Shubham
Filed 2026-09-11
$2.4M
VREX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Pzena Small Cap Value Fund
$1.4M position · as of 2026-05-31
1.5%
State Street(R) SPDR(R) S&P Kensho Future Security ETF
$1.3M position · as of 2026-06-30
0.9%
Zacks Small-Cap Core Fund
$283.4K position · as of 2026-05-31
0.8%
Clearwater Select Equity Fund
$3.1M position · as of 2026-06-30
0.6%
Brighthouse Small Cap Value Portfolio
$4.2M position · as of 2026-06-30
0.6%
Allspring Special Small Cap Value Fund
$17.0M position · as of 2026-06-30
0.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of Homeland Security
PREVENTATIVE AND CORRECTIVE MAINTENANCE OF RADIATION DETECTION EQUIPMENT (RDE) AND LARGE SCALE (LS) · 2024-08-31
$9.7M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Executive pay vs shareholder return · Sunny Sanyal
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$4.5M
$3.7M
$1.2M
+52%
+1%
2022
$4.5M
$1.2M
$1.3M
+71%
-3%
2021
$4.7M
$10.1M
$1.2M
+131%
+29%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.6M sold by insiders over 180 days, 93 funds added last quarter, $2.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$865.0M
four quarters, 2025-07-05 to 2026-07-03
Revenue, TTM VREX
FY Oct 2025
$844.6M
FY Sep 2024
$811.0M
FY Sep 2023
$893.4M
FY Sep 2022
$859.4M
FY Oct 2021
$818.1M
Jul 2026
$210.5M
Apr 2026
$216.0M
Jan 2026
$209.6M
Oct 2025
$228.9M
Jul 2025
$203.0M
Apr 2025
$212.9M
Jan 2025
$199.8M
Sep 2024
$205.7M
At each fiscal year end
Single quarter
Net margin, TTM
+2.6%
net income over revenue, 2025-07-05 to 2026-07-03
Net margin, TTM VREX
FY Oct 2025
-8.3%
FY Sep 2024
-6.0%
FY Sep 2023
+5.3%
FY Sep 2022
+3.5%
FY Oct 2021
+2.1%
Jul 2026
+7.5%
Apr 2026
-3.8%
Jan 2026
+1.1%
Oct 2025
+5.3%
Jul 2025
-43.9%
Apr 2025
+3.2%
Jan 2025
-0.2%
Sep 2024
-24.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$20.2M
operating cash flow minus capex, 2025-07-05 to 2026-07-03
Free cash flow, TTM VREX
FY Oct 2025
$18.8M
FY Sep 2024
$20.4M
FY Sep 2023
$87.7M
FY Sep 2022
-$4.4M
FY Oct 2021
$77.5M
Jul 2026
$12.0M
Apr 2026
-$7.7M
Jan 2026
-$26.8M
Oct 2025
$2.3M
Jul 2025
$1.4M
Apr 2025
$9.8M
Jan 2025
$5.3M
Sep 2024
$19.9M
At each fiscal year end
Single quarter
Debt to equity
0.70x
long-term 2026-07-03 plus current 2026-07-03; equity 2026-07-03
Debt to equity VREX
FY Oct 2025
0.78x
FY Sep 2024
0.84x
FY Sep 2023
0.78x
FY Sep 2022
0.78x
FY Oct 2021
0.90x
Jul 2026
0.70x
Apr 2026
0.73x
Jan 2026
0.77x
Oct 2025
0.78x
Jul 2025
0.81x
Apr 2025
1.03x
Jan 2025
1.05x
Sep 2024
0.84x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.03x
TTM operating cash flow over long-term 2026-07-03 plus current 2026-07-03
Cash flow to debt VREX
FY Oct 2025
0.11x
FY Sep 2024
0.11x
FY Sep 2023
0.24x
FY Sep 2022
0.04x
FY Oct 2021
0.21x
Jul 2026
0.03x
Apr 2026
-0.01x
Jan 2026
0.04x
Oct 2025
0.11x
Jul 2025
0.16x
Apr 2025
0.11x
Jan 2025
0.08x
Sep 2024
0.11x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+4.6%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on equity VREX
FY Oct 2025
-14.0%
FY Sep 2024
-8.9%
FY Sep 2023
+8.6%
FY Sep 2022
+6.0%
FY Oct 2021
+3.7%
Jul 2026
+4.6%
Apr 2026
-16.2%
Jan 2026
-13.3%
Oct 2025
-14.0%
Jul 2025
-25.8%
Apr 2025
-7.7%
Jan 2025
-8.8%
Sep 2024
-8.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.0%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on assets VREX
FY Oct 2025
-6.1%
FY Sep 2024
-4.0%
FY Sep 2023
+3.9%
FY Sep 2022
+2.6%
FY Oct 2021
+1.5%
Jul 2026
+2.0%
Apr 2026
-6.8%
Jan 2026
-5.6%
Oct 2025
-6.1%
Jul 2025
-11.5%
Apr 2025
-3.3%
Jan 2025
-3.8%
Sep 2024
-4.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+8.3%
operating income after a 18.8% effective tax rate, over long-term 2026-07-03 plus current 2026-07-03 plus average of 2025-07-04 and 2026-07-03 minus cash
Return on invested capital VREX
FY Oct 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
+7.6%
FY Oct 2021
+6.0%
Jul 2026
+8.3%
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+8.0%
operating income (EBIT proxy) over average of 2025-07-04 and 2026-07-03 minus current liabilities
Return on capital employed VREX
FY Oct 2025
-2.9%
FY Sep 2024
+3.1%
FY Sep 2023
+7.3%
FY Sep 2022
+8.9%
FY Oct 2021
+7.6%
Jul 2026
+8.0%
Apr 2026
-3.0%
Jan 2026
-2.2%
Oct 2025
-2.9%
Jul 2025
-3.7%
Apr 2025
+4.7%
Jan 2025
+3.4%
Sep 2024
+3.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
34.83x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-05 to 2026-07-03
P/E, trailing VREX
FY Oct 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
17.73x
FY Sep 2022
28.96x
FY Oct 2021
68.05x
Jul 2026
20.02x
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.0B
market value at close 2026-10-27 on 2026-08-03 shares, plus long-term 2026-07-03 plus current 2026-07-03, minus cash 2026-07-03
Enterprise value VREX
FY Oct 2025
$718.0M
FY Sep 2024
$762.2M
FY Sep 2023
$1.0B
FY Sep 2022
$1.2B
FY Oct 2021
$1.4B
Jul 2026
$694.6M
Apr 2026
$702.2M
Jan 2026
$733.9M
Oct 2025
$718.0M
Jul 2025
$596.3M
Apr 2025
$703.2M
Jan 2025
$977.1M
Sep 2024
$762.2M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-2.6%
TTM free cash flow over market value at close 2026-10-27
FCF yield VREX
FY Oct 2025
+3.8%
FY Sep 2024
+4.2%
FY Sep 2023
+11.6%
FY Sep 2022
-0.5%
FY Oct 2021
+6.9%
Jul 2026
-4.5%
Apr 2026
-7.0%
Jan 2026
-2.7%
Oct 2025
+3.8%
Jul 2025
+10.0%
Apr 2025
+11.2%
Jan 2025
+4.4%
Sep 2024
+4.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing VREX
FY Oct 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
0.39x
FY Sep 2022
0.39x
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
VREX ranks highest on profitability (50th percentile) and risk and compliance (44th), and lowest on institutional and government (27th), among Semiconductors & Electronics peers.
Profitability
50
Inputs
Return on equity+4.6% · 52 pct, sector of 154
Return on assets+2.0% · 54 pct, sector of 171
Return on invested capital+8.3% · 29 pct, sector of 56
Return on capital employed+8.0% · 65 pct, sector of 155
Financial health
35
Inputs
Debt to equity0.70x · 26 pct, sector of 152
Cash flow to debt0.03x · 44 pct, sector of 136
Growth
34
Inputs
Revenue growth, YoY+4.1% · 40 pct, sector of 194
Backlog growth, YoY-16.2% · 28 pct, sector of 51
Insider conviction
28
Inputs
Net Form 4 buying (codes P and S), 180d-$2.6M · 56 pct, sector of 146
Insider buyers, 180d0 · 0 pct, sector of 150
Institutional and government
27
Inputs
Funds adding, latest quarter93 · 39 pct, sector of 184
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$80K · 15 pct, sector of 53
Risk and compliance
44
Inputs
Short interest, % of float+3.9% · 59 pct, sector of 220
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+17.9% · 28 pct, sector of 152
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
VREX filings, in plain words
Are Varex Imaging insiders buying or selling VREX?
In the 180 days to 2026-10-28, Varex Imaging insiders were net sellers, a net $2.6M across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of VREX?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $2.6M of stock; the latest, by Kunkel Jay K., was filed 2026-09-14.
Read the full summary
In the 180 days to 2026-10-28, Varex Imaging insiders were net sellers of VREX, a net $2.6M across purchases and sales reported on Form 4 by 2 sellers. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $2.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.